Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Oncology Information Systems Market Size & Growth Forecast 2026–2035, By Segments (Products & Services, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 14551| Published Date: Jun-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Oncology Information Systems Market size was valued at USD 3.05 Billion in 2025 and is projected to grow at a 7.9% CAGR from 2026 to 2035, crossing USD 6.52 Billion by 2035. The industry revenue for 2026 is estimated at USD 3.26 billion.

Base Year Value (2025)
USD 3.05 Billion
CAGR (2026-2035)
7.9%
Forecast Year Value (2035)
USD 6.52 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Oncology Information Systems Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 42.05% share in 2025, supported by advanced cancer care infrastructure, integrated hospital IT systems, and strong demand for coordinated oncology workflows.
  • Asia Pacific is projected to expand at an 8.93% CAGR as healthcare providers modernize cancer care, adopt digital workflows, and improve treatment coordination across expanding hospital networks.

Segment Momentum

  • Solutions captured 71.03% of the market in 2025 because providers rely on integrated platforms for treatment planning, patient records, scheduling, and coordinated oncology workflows across multidisciplinary care teams.
  • Medical oncology continues growing rapidly because systemic cancer treatment requires continuous documentation, regimen management, and long-term patient monitoring, making information systems essential for daily clinical operations.

Market Expansion Drivers

  • Increasing global cancer incidence driving demand for integrated oncology information platforms.
  • AI-driven treatment planning and real-time monitoring transforming oncology clinical workflows.
  • Hospital digitalization and EHR integration improving oncology data management efficiency.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent players in the oncology information systems market include Elekta AB (Sweden), Siemens Healthineers AG (Germany), Oracle Corporation (United States), Koninklijke Philips N.V. (Netherlands), RaySearch Laboratories AB (Sweden), Accuray Incorporated (United States), Brainlab AG (Germany), Flatiron Health, Inc. (United States), DOSIsoft SA (France), Prowess, Inc. (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Increasing global cancer incidence driving demand for integrated oncology information platforms

Rising cancer volumes are putting sustained pressure on providers to manage more patients, longer treatment pathways, and increasingly complex combinations of imaging, radiation oncology, medical oncology, and follow-up care. This is driving demand for the oncology information systems market because fragmented records and disconnected departmental tools make scheduling, treatment documentation, dose tracking, and multidisciplinary coordination harder to manage at scale. As cancer caseloads grow, health systems are prioritizing integrated oncology information platforms that consolidate clinical data, streamline care pathways, and reduce operational bottlenecks, supporting market expansion through replacement of siloed systems and broader deployment of centralized oncology workflow infrastructure.

AI-driven treatment planning and real-time monitoring transforming oncology clinical workflows

AI-enabled planning and monitoring tools are changing how oncology teams use software by embedding decision support directly into treatment design, image review, and ongoing patient management. In the oncology information systems market, this is influencing market adoption as providers seek platforms that can incorporate algorithm-assisted contouring, treatment optimization, toxicity tracking, and alert-based monitoring without disrupting clinical throughput. Demand is shifting toward systems that can turn large volumes of oncology data into actionable workflow inputs, which strengthens market development by making the information system a core operational layer in precision oncology rather than a passive documentation environment.

Hospital digitalization and EHR integration improving oncology data management efficiency

As hospitals modernize core IT environments, oncology departments are under pressure to align specialized cancer care workflows with enterprise-wide digital infrastructure. This is supporting market expansion in the oncology information systems market because buyers increasingly favor platforms that integrate cleanly with electronic health records, laboratory systems, imaging repositories, and billing tools, reducing duplicate data entry and improving continuity between oncology and the rest of the hospital. Integration capability shapes procurement decisions in practice: systems that enable faster information exchange, more reliable documentation, and better visibility into treatment histories are gaining traction as providers pursue more efficient oncology data management and standardized clinical operations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Growing adoption of oncology information systems in hospitals 2.90% Short term (≤ 2 yrs) North America, Europe (spillover: Asia Pacific) High Fast
Rising demand for integrated healthcare data management 2.60% Medium term (2–5 yrs) Asia Pacific, North America (spillover: Europe) High Moderate
Advances in AI & predictive analytics in oncology care 2.10% Long term (5+ yrs) Europe, North America (spillover: Asia Pacific) High Slow
Increasing global cancer incidence driving demand for integrated oncology information platforms 2.20% High North America, Asia Pacific High Near Term
AI-driven treatment planning and real-time monitoring transforming oncology clinical workflows 2.00% High North America, Europe High Mid Term
Hospital digitalization and EHR integration improving oncology data management efficiency 1.60% High North America, Asia Pacific High Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
42.05% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 42.05% share of the oncology information systems market in 2025, backed by the region’s established cancer care infrastructure, broad use of integrated hospital IT environments, and steady demand for workflow coordination across radiation oncology, medical oncology, and patient data management. Its leadership is reinforced by the practical need among providers to connect treatment planning, clinical documentation, scheduling, and reporting within unified systems, particularly in care settings managing high patient volumes and complex multidisciplinary treatment pathways.

Asia Pacific is projected to expand at an 8.93% CAGR over the forecast period, with growth in the oncology information systems market being impelled by the ongoing modernization of healthcare delivery and rising adoption of digital systems in cancer care. Momentum is coming from providers that are moving beyond fragmented records toward more structured oncology workflows, where information systems help improve case tracking, treatment coordination, and data accessibility as cancer services scale across larger hospital networks and developing care environments.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Digital Oncology Coordination

Germany emphasizes oncology information systems that standardize cancer care workflows across hospitals and specialized treatment centers. Healthcare organizations increasingly adopt integrated platforms to improve clinical documentation, treatment accuracy, and regulatory compliance.

France 🇫🇷

Coordinated Treatment Platforms

France is expanding the use of oncology information systems to improve collaboration between oncology departments and regional healthcare networks. Hospitals prioritize platforms that streamline patient records, radiation planning, and long-term treatment management.

Italy 🇮🇹

Clinical Workflow Modernization

Italy is modernizing oncology information systems to enhance cancer care coordination and improve access to consolidated patient information. Healthcare institutions increasingly adopt digital platforms that simplify treatment documentation and multidisciplinary collaboration.

Japan 🇯🇵

Precision Care Integration

Japan advances oncology information systems that support personalized treatment planning and efficient management of complex oncology data. Healthcare providers focus on solutions that enhance workflow consistency while integrating diagnostic and therapeutic information.

South Korea 🇰🇷

Smart Cancer Management

South Korea invests in oncology information systems that strengthen digital cancer care delivery across advanced healthcare facilities. Providers increasingly integrate analytics, treatment planning, and patient management capabilities to improve operational efficiency and clinical decision-making.

United States 🇺🇸

Integrated Cancer Informatics

The U.S. continues expanding oncology information systems that connect treatment planning, imaging, electronic health records, and clinical workflows. Healthcare providers prioritize interoperable platforms that improve multidisciplinary care coordination and support precision oncology practices.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Oncology Information Systems Market Share (%), Products & Services, 2025

Solutions
Professional Services

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Products & Services Segment Analysis: Solutions (Largest & Fastest-Growing Segment)

Within the oncology information systems market, Solutions held a 71.03% share in 2025, reflecting its central role in managing the clinical, operational, and data-intensive workflows used across cancer care settings. This leadership is underpinned by the need for integrated platforms that support treatment planning, patient record management, scheduling, and coordination across multidisciplinary oncology teams, making solutions the core technology layer rather than an optional add-on. The same practical dependence is also driving continued growth, as providers increasingly prioritize unified oncology information systems that can streamline complex care pathways, reduce workflow fragmentation, and handle rising volumes of oncology data more effectively.

Application Segment Analysis: Medical Oncology (Largest & Fastest-Growing Segment)

In 2025, Medical Oncology accounted for a 59.96% share of the oncology information systems market, backed by the broad and routine use of systemic cancer treatment workflows that require continuous documentation, regimen management, and longitudinal patient monitoring. Its market leadership comes from the operational intensity of medical oncology practice, where providers depend heavily on information systems to manage treatment protocols, follow-up cycles, and evolving patient records over extended care periods. That same reliance is reinforcing growth momentum, as the expanding complexity of therapy management and ongoing need for coordinated data handling make medical oncology the application area where oncology information systems deliver the most immediate day-to-day value.

Segment Sub-Segment Largest Segment Fastest Growing
Products & Services Solutions, Professional Services Solutions Solutions
Application Medical Oncology, Radiation Oncology, Surgical Oncology Medical Oncology Medical Oncology
End-use Hospitals and Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities Hospitals and Diagnostic Imaging Centers Ablation Care Centers and Cancer Care Centers
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the oncology information systems market:

1. Elekta AB (Sweden)

2. Siemens Healthineers AG (Germany)

3. Oracle Corporation (United States)

4. Koninklijke Philips N.V. (Netherlands)

5. RaySearch Laboratories AB (Sweden)

6. Accuray Incorporated (United States)

7. Brainlab AG (Germany)

8. Flatiron Health Inc. (United States)

9. DOSIsoft SA (France)

10. Prowess Inc. (United States)

The oncology information systems market is witnessing rapid adoption of digital healthcare platforms for improved cancer care management. Advanced data integration is enhancing treatment planning efficiency. The oncology information systems market is evolving toward more connected and intelligent healthcare ecosystems.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Cosylab Jun-26 Cosylab received FDA 510(k) clearance for PlanOne™, a treatment planning system for particle therapy. The platform utilizes a GPU-accelerated Monte Carlo engine for radiobiologically informed dose planning within a unified clinical workflow. This launch expands capabilities for adaptive radiation therapy and AI-driven clinical workflows, enhancing precision and scalability for oncology centers.
Flatiron Health Feb-26 Flatiron Health launched AI-powered Panoramic prostate cancer datasets, aggregating structured and unstructured EHR data for approximately 400,000 patients across the US, UK, and Germany. By utilizing a unified common data model for multi-modal clinical intelligence, the platform supports enhanced therapy development and clinical evidence generation for global oncology research and treatment planning applications.
GE HealthCare Sep-25 GE HealthCare updated its Intelligent Radiation Therapy (iRT) software to improve workflow management and connectivity. The enhancements focus on integrating third-party applications and AI-supported tools to streamline the diagnostic-to-treatment pathway. This update aims to optimize departmental efficiency and clinical decision-making processes within radiation oncology operations.
RaySearch Laboratories AB Sep-25 RaySearch Laboratories released RayIntelligence v2025, an update to its cloud-based oncology analytics platform. The release introduces customizable dashboards for tracking key performance indicators, including plan quality trends, machine utilization, protocol adherence, and clinical outcome analysis. This tool supports data-driven operational oversight and workflow optimization for healthcare institutions.
RaySearch Laboratories AB Jun-25 RaySearch Laboratories introduced RayCare v2025, featuring enhanced integrations for patient documentation and imaging workflows. Key upgrades include Microsoft Word integration, automated DICOM Modality Worklist capabilities, and HL7 inbound scheduling from hospital information systems. These improvements aim to streamline administrative and clinical data management within the oncology information system.
RaySearch Laboratories AB May-25 RaySearch Laboratories released RayStation v2025, the latest iteration of its treatment planning system. The update provides enhancements to core clinical workflows, supporting more efficient radiation therapy planning and execution. This release strengthens the platform’s competitive position in providing comprehensive planning solutions for advanced oncology care across diverse clinical settings.
GE HealthCare May-25 GE HealthCare expanded its radiation oncology portfolio with the introduction of AI-enabled MR Contour DL for organ-at-risk segmentation. The company also announced plans to integrate Spectronic Medical’s MRI Planner to support MR-only radiotherapy workflows. These additions enhance treatment planning precision, particularly for head, neck, and pelvic region interventions.
RaySearch Laboratories AB Aug-24 The Connecticut Proton Therapy Center integrated RaySearch Laboratories’ RayCare oncology information system with the IBA ProteusONE proton therapy platform. This deployment leverages the interoperability of the RayCare system to enhance operational efficiency for both treatment planning and delivery, demonstrating the strategic adoption of integrated information systems in complex particle therapy environments.
RaySearch Laboratories AB Jan-24 RaySearch Laboratories launched RayStation 2024A, which improves clinical workflows for radiation treatment planning. The release emphasizes increased integration with the company’s RayIntelligence analytics platform, facilitating a more cohesive data environment for oncology departments. This move aligns with broader industry trends toward integrating planning systems with advanced data analytics for improved clinical outcomes.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Oncology Information Systems Market — Custom Segments

Segment Sub-Segment
No segment data available.

Oncology Information Systems Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market size of oncology information systems?

The market size of the oncology information systems is estimated at USD 3.26 billion in 2026.

How is the oncology information systems industry expected to grow over the next 10 years?

Oncology Information Systems Market size is expected to advance from USD 3.05 billion in 2025 to USD 6.52 billion by 2035 registering a CAGR of more than 7.9% across 2026-2035.

How is rising global cancer incidence influencing adoption of integrated oncology information systems in healthcare providers?

Increasing cancer caseloads are driving demand for integrated systems that unify clinical data, scheduling, and treatment workflows. Providers adopt these platforms to reduce fragmentation, improve coordination, and manage complex multi-step oncology care pathways more efficiently.

How are AI-enabled treatment planning and hospital digitalization reshaping oncology information system deployment?

AI tools enhance treatment planning, monitoring, and workflow decision support, making systems more central to clinical operations. Combined with hospital digitalization and EHR integration, this improves data flow, reduces duplication, and strengthens coordinated care delivery.

Why do solutions dominate the oncology information systems market?

Solutions captured 71.03% of the market in 2025 because providers rely on integrated platforms for treatment planning, patient records, scheduling, and coordinated oncology workflows across multidisciplinary care teams.

Why is medical oncology the fastest-growing application in the oncology information systems market?

Medical oncology continues growing rapidly because systemic cancer treatment requires continuous documentation, regimen management, and long-term patient monitoring, making information systems essential for daily clinical operations.

Why is North America the leading region in the oncology information systems market?

North America held a 42.05% share in 2025, supported by advanced cancer care infrastructure, integrated hospital IT systems, and strong demand for coordinated oncology workflows.

What factors are accelerating oncology information systems adoption in Asia Pacific?

Asia Pacific is projected to expand at an 8.93% CAGR as healthcare providers modernize cancer care, adopt digital workflows, and improve treatment coordination across expanding hospital networks.

Which organizations are considered leaders in the oncology information systems landscape?

Prominent players in the oncology information systems market include Elekta AB (Sweden), Siemens Healthineers AG (Germany), Oracle Corporation (United States), Koninklijke Philips N.V. (Netherlands), RaySearch Laboratories AB (Sweden), Accuray Incorporated (United States), Brainlab AG (Germany), Flatiron Health, Inc. (United States), DOSIsoft SA (France), Prowess, Inc. (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →